SCHEMBL1276739

SCHEMBL1276739

Cc1ccc(NC(=S)Nc2ccc(C)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.79
CYP3A4 P08684 3/20 0.79
CYP1A2 P05177 2/20 0.79
CYP2C19 P33261 2/20 0.79
MEN1 O00255 2/20 0.79
HTT P42858 1/20 0.79
GAA P10253 3/20 0.64
NPSR1 Q6W5P4 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
SMN1; SMN2 Q16637 4/20 0.62
NPC1 O15118 4/20 0.61
RAB9A P51151 4/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
ALDH1A1 P00352 5/20 0.61
MAPT P10636 4/20 0.61
KDM4E B2RXH2 1/20 0.61
THRB P10828 1/20 0.61
POLB P06746 1/20 0.60
HPGD P15428 1/20 0.57
TAS2R38 P59533 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1310574 0.91 GAA (0.78) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL5451731 0.91 ALDH1A1 (0.74) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL11074089 0.89 HTT (0.66) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL1747930 0.89 KMT2A (0.66) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL2590098 0.88 CYP1A2 (0.64) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL1882197 0.88 CYP1A2 (0.70) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL8614488 0.87 ALDH1A1 (0.64) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL455272 0.86 IDO1 (0.64) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL16639672 0.85 CYP1A2 (0.73) KMT2ACYP3A4CYP1A2CYP2C19MEN1
SCHEMBL25943052 0.84 GAA (0.65) KMT2ACYP3A4CYP1A2CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119330805-A Preparation method of 3, 5-di-tert-butyl benzyl alcohol 宁夏忠同生物科技有限公司 2025-01-21 CN claimed
CN-119144326-A Preparation method of lead chalcogen quantum dot material 清华大学 2024-12-17 CN claimed
CN-113906321-B Polarizing plate, method for manufacturing same, and image display device 住友化学株式会社 2024-10-15 CN claimed
CN-112545900-B Dental curable composition containing transition metal adsorbent 株式会社松风 2024-02-13 CN claimed
CN-115368282-A Method for synthesizing 1, 3-disubstituted thiourea in aqueous phase 吉安宏达秋科技有限公司 2022-11-22 CN claimed
EP-3425710-B1 PROCESS FOR THE PREPARATION OF NANOPARTICLES FREE OF NOBLE METALS AND THEIR USE IN OXYGEN REDUCTION COMMISSARIAT ENERGIE ATOMIQUE (FR) 2021-06-16 EP claimed
CN-112011327-A Preparation method of core-shell structure quantum dot and product prepared by same 苏州星烁纳米科技有限公司 2020-12-01 CN claimed
EP-3425710-A1 PROCESS FOR THE PREPARATION OF NANOPARTICLES FREE OF NOBLE METALS AND THEIR USE IN OXYGEN REDUCTION Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2019-01-09 EP claimed
EP-0928320-B1 STEAM STERILIZATION INDICATOR COMPOSITIONS MINNESOTA MINING & MFG (US) 2003-07-02 EP claimed
EP-0928320-A2 STEAM STERILIZATION INDICATOR COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-07-14 EP claimed
US-5916816-A COMPRISING A BISMUTH COMPOUND, A SULFUR SOURCE, AND A COMPOUND CAPABLE OF GENERATING ALKALINE CONDITIONS WHEN EXPOSED TO STEAM MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-06-29 US claimed
WO-1998013431-A2 STEAM STERILIZATION INDICATOR COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-04-02 WO claimed
EP-0569038-B1 A reversible electrode MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 1996-01-03 EP claimed
US-5370947-A Comprising thiourea compounds or polythioureas; oxidation-reduction of sulfur atoms; lightweight batteries MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1994-12-06 US claimed
EP-0569038-A1 A reversible electrode MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1993-11-10 EP claimed
CN-121609657-B Catalytic hydrogenation method of thiourea compound, ruthenium-based multi-tooth ligand compound and application thereof 浙江大学 2026-05-19 CN disclosed
US-20260083644-A1 METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE SHOFU INC (JP) 2026-03-26 US disclosed
US-4313771-A Laser hardening of steel work pieces XEROX CORPORATION (US) 1982-02-02 US disclosed
EP-0035401-A1 Heat treatment of steel work pieces XEROX CORPORATION (US) 1981-09-09 EP disclosed
US-4252963-A CYCLIZATION OF PHENYLTHIOUREAS WITH THIONYL CHLORIDE HOECHST AKTIENGESELLSCHAFT (DE) 1981-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260083644-A1 METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE ARCN1, LBR, POLL KMT2A 4073/4885CYP3A4 2914/4885CYP1A2 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.